Passage Bio, Inc.

Passage Bio, Inc.verified

PASG

Price:

$5.81

Market Cap:

$18.64M

Passage Bio, Inc. is a biopharmaceutical company dedicated to pioneering genetic therapies for conditions affecting the central nervous system. Their advanced pipeline includes PBGM01, designed to treat infantile GM1 gangliosidosis by utilizing a proprietary AAVhu68 capsid to deliver a functional GLB1 gene, which codes for the lysosomal acid beta-galactosidase enzyme, to both the brain and peripheral tissues. Another key program, PBFT02, employs an AAV1 capsid to introduce a functional granulin (GRN) gene, encoding progranulin (PGRN), to the brain as a treatment for FTD-GRN. Additionally, PBKR03 is under development for infantile Krabbe disease, leveraging a proprietary AAVhu68 capsid to del...[Read more]

Industry

Biotechnology

IPO Date

2020-02-28

Stock Exchange

NASDAQ

Ticker

PASG

The Current Ratio as of June 2026 (TTM) for Passage Bio, Inc. (PASG) is 1.73

According to Passage Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.73. This represents a change of -26.06% compared to the average of 2.34 of the last 4 quarters.

Passage Bio, Inc. (PASG) Historical Current Ratio (quarterly & annually)

How has PASG Current Ratio performed in the past?

The mean historical Current Ratio of Passage Bio, Inc. over the last ten years is 25.49. The current 1.73 Current Ratio has changed 577.93% with respect to the historical average. Over the past ten years (40 quarters), PASG's Current Ratio was at its highest in in the December 2018 quarter at 108.79. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

25.49

Median

10.88

Minimum

2.07

Maximum

108.79

Passage Bio, Inc. (PASG) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Passage Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Current Ratio = 108.79

Minimum Annual Increase = -66.74%

Minimum Annual Current Ratio = 2.07

Quarterly (TTM)
Annual
YearCurrent RatioChange
20252.07-49.17%
20244.07-43.61%
20237.22-32.77%
202210.74-2.56%
202111.02-26.43%
202014.98-66.74%
201945.04-58.60%

Passage Bio, Inc. (PASG) Average Current Ratio

How has PASG Current Ratio performed in the past?

The current Current Ratio of Passage Bio, Inc. (PASG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.45

5-year avg

7.02

10-year avg

25.49

Passage Bio, Inc. (PASG) Current Ratio vs. Peers

How is PASG’s Current Ratio compared to its peers?

Passage Bio, Inc.’s Current Ratio is less than NuCana plc (5.48), less than MetaVia Inc. (2.73), less than Lisata Therapeutics, Inc. (4.23), greater than Allarity Therapeutics, Inc. (1.23), less than CytoMed Therapeutics Limited (5.17), less than Enlivex Therapeutics Ltd. (193.24), less than Cingulate Inc. (2.55), less than CollPlant Biotechnologies Ltd. (2.27), greater than Exicure, Inc. (0.79), greater than CASI Pharmaceuticals, Inc. (0.30),

Build a custom stock screener for Passage Bio, Inc. (PASG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Passage Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Passage Bio, Inc. (PASG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Passage Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Passage Bio, Inc.'s Current Ratio?

How is the Current Ratio calculated for Passage Bio, Inc. (PASG)?

What is the highest Current Ratio for Passage Bio, Inc. (PASG)?

What is the 3-year average Current Ratio for Passage Bio, Inc. (PASG)?

What is the 5-year average Current Ratio for Passage Bio, Inc. (PASG)?

How does the current Current Ratio for Passage Bio, Inc. (PASG) compare to its historical average?